FM
FMR LLC disclosed a 9.5% stake in ALNY
FMR LLC reported owning 9.5% of Alnylam Pharmaceuticals, Inc. (ALNY) (12,675,053 shares) in a Schedule 13G filed Nov 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 5, 2026
- Source
- Schedule 13G